Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TEVA-RISEDRONATE DIN 02413809

Status: Marketed
Holder: TEVA CANADA LIMITED
Molecule: RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE)
Available to quote

Health Canada record

Active ingredient(s)RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 150 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCM05BA07 RISEDRONIC ACID
Original market date10-Oct-2013
Current status date10-Oct-2013
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE)

DINProductCompanyFormStrengthStatus
02411407RISEDRONATESIVEM PHARMACEUTICALS ULCTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 35 MGMarketed
02298384TEVA-RISEDRONATETEVA CANADA LIMITEDTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 30 MGMarketed
02298392TEVA-RISEDRONATETEVA CANADA LIMITEDTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 35 MGMarketed
02298376TEVA-RISEDRONATETEVA CANADA LIMITEDTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 5 MGMarketed
02358883NTP-RISEDRONATENT PHARMA CANADA LTDTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 5 MGCancelled Pre Market
02358891NTP-RISEDRONATENT PHARMA CANADA LTDTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 30 MGCancelled Pre Market
02358905NTP-RISEDRONATENT PHARMA CANADA LTDTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 35 MGCancelled Pre Market
02370239RISEDRONATESANIS HEALTH INCTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 5 MGCancelled Pre Market
02370247RISEDRONATESANIS HEALTH INCTabletRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 30 MGCancelled Pre Market
02326981TEVA-RISEDRONATE/CALCIUMTEVA CANADA LIMITEDTablet; KitRISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 35 MG; CALCIUM (CALCIUM CARBONATE) 500 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
147972013-10-10Supplement to an Abbreviated New Drug Submission (SANDS)NEW STRENGTH
Request a quote for TEVA-RISEDRONATE

How to read a Canadian DIN record